Erdheim-Chester disease with chorioretinal and orbital involvement: a case report

Kubra Serefoglu Cabuk,Adem Tellioglu,Gamze Ozturk Karabulut,Senay Asik Nacaroglu,Korhan Fazil,Tuğrul Elverdi,Muhittin Taskapili,Safak Karslioglu
DOI: https://doi.org/10.5935/0004-2749.2022-0151
2023-04-03
Abstract:A 42-year-old woman presented with bilateral proptosis, chemosis, leg pain, and vision loss. Orbital, chorioretinal, and multi-organ involvement of Erdheim-Chester disease, a rare non-Langerhans histiocytosis, with a negative BRAF mutation was diagnosed based on clinical, radiological, and pathological findings. Interferon-alpha-2a (IFNα-2a) was started, and her clinical condition improved. However, 4 months later, she had vision loss with a history of IFNα-2a cessation. The same therapy was administered, and her clinical condition improved. The Erdheim-Chester disease is a rare chronic histiocytic proliferative disease that requires a multidisciplinary approach and can be fatal if left untreated because of multisystemic involvements.
What problem does this paper attempt to address?